Legal
Filter News
Found 9,365 articles
-
Catalyst Pharmaceuticals Announces Filing of Patent Infringement Actions Against Jacobus Pharmaceuticals and PantherRx
10/19/2020
Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating, chronic neuromuscular and neurological diseases, today announced that it has filed a lawsuit in the U.S. District Court for New Jersey against Jacobus Pharmaceuticals, Inc. (Jacobus), and a lawsuit in the U.S. District Court for the Western Di
-
This week, the judge overseeing her trial denied all efforts from her legal team to dismiss more than a dozen criminal charges against the Theranos founder.
-
Mallinckrodt has filed for Chapter 11 bankruptcy amid growing lawsuits that allege the company has participated in fueling the opioid epidemic in the United States.
-
Charles M. Lieber is currently on paid leave from Harvard’s chemistry department after his arrest in January on charges of lying to the U.S. government about funds received from China.
-
Merit Medical Systems Finalizes Resolution with the Government
10/13/2020
Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy, announced today that it has finalized its settlement with the U.S. Department of Justice and the U.S. Department of Health and Human Services. In order to avoid distraction from its core mi
-
LTC ACO Receives Positive Reconciliation and Settlement Under the Medicare Shared Savings Program (MSSP)
10/13/2020
LTC ACO, the first long-term care sponsored Accountable Care Organization (“ACO”) in the United States and a subsidiary of Genesis HealthCare (Genesis) (NYSE:GEN), recently received a positive reconciliation and settlement under the Medicare Shared Savings Program (“MSSP”) for the 2019 performance year and as a result, generated shared savings for the second consecutive year. During 2019, the Company managed approximately 5,800 Medicare
-
A 41-year-old man from Richland, Wash. was convicted on 47 counts of fraud and drug related charges on Oct. 1, according to the U.S. Justice Department’s Eastern District of Washington.
-
Allele Biotechnology and Pharmaceuticals filed lawsuits claiming the companies infringed on Allele’s patented mNeonGreen technology in the development of their COVID-19 treatments.
-
In the October 2 verdict, Circuit Judge Pauline Newman said that promotional materials, press releases, product catalogs, FDA labels and witness testimony did support the “induced infringement” judgement against Teva.
-
IMED Surgical Files Federal Lawsuit Against Orthex, Dror Paley, OrthoPediatrics, and Squadron CapitalT
10/6/2020
IMED Surgical, LLC (“IMED”), a technology-based orthopedics medical device developer and manufacturer based in New Jersey, announced today that the company has filed a federal lawsuit against Dror Paley, Founder and Director of the Paley Orthopedic and Spine Institute; Orthex, LLC (“Orthex”), a wholly-owned subsidiary of OrthoPediatrics; OrthoPediatrics Corp.
-
Allele Biotechnology and Pharmaceuticals Files Two Lawsuits for Patent Infringement for the Unauthorized Use of mNeonGreen in Development and Testing of COVID Vaccines and Therapeutics
10/6/2020
New York Lawsuit Filed Against Regeneron Pharmaceuticals, Inc. California Lawsuit Filed Against Pfizer, Inc. and BioNTech SE and BioNTech U.S., Inc. SAN DIEGO--( BUSINESS WIRE )-- Allele Biotechnology and Pharmaceuticals, Inc. (“Allele”), a San Diego-based company focused on developing and adapting cutting edge technology for clinical and therapeutic use, filed two patent infringement lawsuits today – one in New York against Regenero
-
Philadelphia-based software company eResearchTechnology (ERT), which offers software used in hundreds of clinical trials, has suffered a ransomware attack.
-
Cocrystal Pharma Announces Notice of Pendency and Proposed Settlement of Stockholder Derivative Actions
10/2/2020
Cocrystal Pharma, Inc. (NASDAQ: COCP) The following is being released by Cocrystal Pharma, Inc. pursuant to an order of the United States District Court, District of New Jersey, regarding Agreement of Settlement. UNITED STATES DISTRICT COURT DISTRICT OF NEW JERSEY TRENT NICHOLS and SHARON NICHOLS, derivatively on behalf of COCRYSTAL PHARMA, INC. F/K/A BIOZONE PHARMACEUTICALS, INC., Plaintiffs, vs. ELLI
-
B. Braun Medical Inc. announces that it has previously settled its Hatch-Waxman litigation brought by Mallinckrodt
10/2/2020
B. Braun Medical Inc. announces that it has previously settled a patent infringement litigation brought by Mallinckrodt Hospital Products Inc., its affiliates, and New Pharmatop L.P. in response to B. Braun's new drug application (NDA) seeking approval to market its (acetaminophen) injection product
-
Judge Rules Tamiflu-Maker Hoffman-La Roche Must Answer Whistleblower Fraud Claims
10/1/2020
Tamiflu-maker Hoffman-La Roche (OTCMKTS – RHHBY) must answer to whistleblower charges that it falsified claims of Tamiflu's effectiveness in fighting influenza and fraudulently induced the federal government to stockpile millions of doses f
-
Catalyst Pharmaceuticals is reeling this morning after a federal judge dismissed the company’s lawsuit against the U.S. Food and Drug Administration regarding the approval of a rival drug for a rare autoimmune disease from New Jersey-based Jacobus Pharmaceutical.
-
Collegium Announces Settlement with Teva Resolving Xtampza® ER Patent Litigation
9/30/2020
Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being the leader in responsible pain management, today announced that it has reached a settlement agreement with Teva Pharmaceutical USA, Inc. (Teva) that resolves patent litigation brought in response to Teva’s Abbreviated New Drug Application (ANDA), seeking approval to market a generic version of Xtampza ER prior to the expiration of Collegium
-
U.S. Stem Cell Confirms Date for Appeals Court Oral Arguments
9/30/2020
U.S. Stem Cell, Inc. , is pleased to announce that oral arguments for the companys court case USA v. U.S. Stem Cell Clinic, et al has been set for the docket beginning January 11, 2021.
-
Catalyst Pharmaceuticals Announces Ruling on Lawsuit against the FDA and Intent to Appeal
9/29/2020
Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), today reported that the federal judge handling Catalyst's case against the FDA has adopted the previously reported Report and Recommendation of the Magistrate Judge, granted summary judgment in favor of the FDA and Jacobus, and dismissed Catalyst's case.
-
Governor Newsom Signs AB 1710 (Wood)
9/25/2020
Governor Newsom has signed AB 1710, a CPhA-sponsored bill, which grants pharmacists the authority to independently initiate and administer a COVID-19 vaccine, once one has been approved or authorized by the federal Food and Drug Administration.